Echinococcus Species and Genotypes Causing Human Cystic Echinococcosis
Human cystic echinococcosis is primarily caused by Echinococcus granulosus sensu stricto (genotypes G1-G3), which accounts for approximately 88% of cases worldwide, followed by E. canadensis (genotypes G6-G7, G8, G10) responsible for about 11% of infections, and rarely by E. ortleppi (genotype G5). 1
Primary Causative Species and Genotypes
The most recent and comprehensive molecular epidemiological data confirms the following distribution:
E. granulosus sensu stricto (G1-G3)
- Genotype G1 is the dominant cause globally, responsible for 88.44% of human cystic echinococcosis cases 1
- Has the most cosmopolitan distribution worldwide
- Primarily transmitted via sheep as intermediate hosts
- Found in the UK most commonly in migrants from Eastern Europe, Middle East, and North Africa 2
E. canadensis (G6-G7, G8, G10)
Collectively responsible for 11.07% of human infections 1
Genotype G6 accounts for 7.34% of cases worldwide:
- Transmitted mainly by camels and goats in Africa and Asia
- Transmitted by goats in South America
- Recent comprehensive mitogenome analysis revealed subdivision into two major haplogroups: G6a (nominal) and G6b (Mongolian) 3
Genotype G7 causes 3.73% of human cases:
Genotypes G8 and G10 cause rare human infections 1
E. ortleppi (G5)
- Causes rare cases of human cystic echinococcosis 1
E. equinus (G4)
- No documented cases of human infection in the literature 1
- However, one recent 2021 report from Turkey identified the first human case of E. equinus (G4 genotype) 5
Important Clinical Distinctions
It is essential to distinguish E. granulosus (causing cystic echinococcosis) from E. multilocularis (causing alveolar echinococcosis) from the outset, as radiographic appearance, diagnostics, and treatment differ significantly between the two species 2.
Key Differences:
- E. granulosus presents more commonly in UK practice 2
- E. multilocularis is rare in UK practice but more serious, with small interconnected cysts that infiltrate organs and metastasize 6
- Unlike cystic echinococcosis, alveolar echinococcosis lesions can progress rapidly in immunocompromised patients 2
Taxonomic Controversy
Some authorities classify genotypes G6 and G7 as a separate species—E. intermedius, though this classification is not universally accepted. The current molecular evidence supports grouping them under E. canadensis 1, 3.
Clinical Implications of Genotypic Diversity
Recent investigations have revealed important biological differences between genotypes:
- The protective vaccine antigen (EG95) developed for G1 genotype is immunologically different in the G6 genotype 1
- Further research is needed to determine whether current EG95 vaccine would be effective against G6 or G7 genotypes, or whether genotype-specific vaccines are necessary 1
- Biological differences between species and genotypes affect transmission dynamics and may require modification of disease control initiatives 1
Geographic and Host Patterns
Understanding the genotype distribution helps predict likely causative agents based on patient origin and exposure:
- G1 (sheep-associated): Worldwide, especially Mediterranean, Middle East, Eastern Europe
- G6 (camel/goat-associated): Africa, Asia, South America
- G7 (pig-associated): Eastern Europe, particularly Poland 4
- G3: Less common variant of E. granulosus s.s., found in various regions 7, 8
Human infections with E. multilocularis have been documented in endemic regions, though this species causes alveolar rather than cystic echinococcosis 7.